These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30988063)

  • 1. PDK-1 mediated Hippo-YAP-IRS2 signaling pathway and involved in the apoptosis of non-small cell lung cancer cells.
    Wang G; Liu X; Xie J; Meng J; Ni X
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
    Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
    Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells.
    You B; Yang YL; Xu Z; Dai Y; Liu S; Mao JH; Tetsu O; Li H; Jablons DM; You L
    Oncotarget; 2015 Feb; 6(6):4357-68. PubMed ID: 25738359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer.
    Jeong SH; Kim HB; Kim MC; Lee JM; Lee JH; Kim JH; Kim JW; Park WY; Kim SY; Kim JB; Kim H; Kim JM; Choi HS; Lim DS
    J Clin Invest; 2018 Mar; 128(3):1010-1025. PubMed ID: 29400692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway.
    Liu XF; Han Q; Rong XZ; Yang M; Han YC; Yu JH; Lin XY
    Int J Oncol; 2020 May; 56(5):1175-1185. PubMed ID: 32319569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aqueous extract of Taxus chinensis var. mairei regulates the Hippo-YAP pathway and promotes apoptosis of non-small cell lung cancer via ATF3 in vivo and in vitro.
    Zhang G; Dai S; Chen Y; Wang H; Chen T; Shu Q; Chen S; Shou L; Cai X
    Biomed Pharmacother; 2021 Jun; 138():111506. PubMed ID: 33740524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC).
    Hsu PC; Jablons DM; Yang CT; You L
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yes-associated protein regulates the growth of human non-small cell lung cancer in response to matrix stiffness.
    Yuan Y; Zhong W; Ma G; Zhang B; Tian H
    Mol Med Rep; 2015 Jun; 11(6):4267-72. PubMed ID: 25607725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YAP-TEAD up-regulates IRS2 expression to induce and deteriorate oesophageal cancer.
    Xu X; Nie J; Lu L; Du C; Meng F; Song D
    J Cell Mol Med; 2021 Mar; 25(5):2584-2595. PubMed ID: 33570213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YAP mediates the positive regulation of hnRNPK on the lung adenocarcinoma H1299 cell growth.
    Xu L; Zhang T; Huang W; Liu X; Lu J; Gao X; Zhang YF; Liu L
    Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):677-687. PubMed ID: 31187136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A7 promotes lung adenocarcinoma to squamous carcinoma transdifferentiation, and its expression is differentially regulated by the Hippo-YAP pathway in lung cancer cells.
    Wang R; Li Y; Hu E; Kong F; Wang J; Liu J; Shao Q; Hao Y; He D; Xiao X
    Oncotarget; 2017 Apr; 8(15):24804-24814. PubMed ID: 28177901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin receptor substrate 2: a bridge between Hippo and AKT pathways.
    Jeong SH; Lim DS
    BMB Rep; 2018 May; 51(5):209-210. PubMed ID: 29699606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Aurora A kinase increases YAP stability via blockage of autophagy.
    Wang P; Gong Y; Guo T; Li M; Fang L; Yin S; Kamran M; Liu Y; Xu J; Xu L; Peng F; Xue X; Yang M; Hung MC; Lam EW; Gu C; Wang C; Zhan Q; Liu Q
    Cell Death Dis; 2019 Jun; 10(6):432. PubMed ID: 31160567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel FAT4 activator jujuboside A suppresses NSCLC tumorigenesis by activating HIPPO signaling and inhibiting YAP nuclear translocation.
    Wang W; Huang Q; Chen Y; Huang Z; Huang Y; Wang Y; Qi X; Liu Z; Lu L
    Pharmacol Res; 2021 Aug; 170():105723. PubMed ID: 34116210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of lncRNA GHET1 suppresses cell proliferation, invasion and LATS1/YAP pathway in non small cell lung cancer.
    Guan ZB; Cao YS; Li Y; Tong WN; Zhuo AS
    Cancer Biomark; 2018 Feb; 21(3):557-563. PubMed ID: 29286919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRE1α-TRAF2-ASK1 pathway is involved in CSTMP-induced apoptosis and ER stress in human non-small cell lung cancer A549 cells.
    Zhang J; Liang Y; Lin Y; Liu Y; YouYou ; Yin W
    Biomed Pharmacother; 2016 Aug; 82():281-9. PubMed ID: 27470364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer.
    Lee HY; Chun KH; Liu B; Wiehle SA; Cristiano RJ; Hong WK; Cohen P; Kurie JM
    Cancer Res; 2002 Jun; 62(12):3530-7. PubMed ID: 12068000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACTL6A promotes the growth in non-small cell lung cancer by regulating Hippo/Yap pathway.
    Ma L; Shan L
    Exp Lung Res; 2021; 47(5):250-259. PubMed ID: 33896314
    [No Abstract]   [Full Text] [Related]  

  • 19. Dichloroacetophenone biphenylsulfone ethers as anticancer pyruvate dehydrogenase kinase inhibitors in non-small cell lung cancer models.
    Guo Y; Zhou Y; Wu P; Ran M; Xu N; Shan W; Sha O; Tam KY
    Chem Biol Interact; 2023 Jun; 378():110467. PubMed ID: 37004952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
    Jiang M; Zhou LY; Xu N; An Q
    Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.